← FDA Drug Approvals (Drugs@FDA)

INSPRA

NDA · New Drug Application · Sponsor: UPJOHN · Approved 2002-09-27

Drug application

FDA Application #

NDA021437

Application type

New Drug Application

Brand name

INSPRA

Generic name

EPLERENONE

Active ingredients

EPLERENONE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

UPJOHN

Manufacturer

Mylan Pharmaceuticals Inc.

First approval

2002-09-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown